Home/Investors & Media/Posters & Presentations/
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein
// February 26, 2024 | CHDI’s 19th Annual Huntington’s Disease Therapeutics Conference Palm Springs, CA
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein